Home/ Stocks/ ABVC

ABVC BioPharma, Inc. Common Stock

ABVC XNAS

$1.02 +0.00 (+0.00%) ▲ 15-min delayed

Open

$1.04

High

$1.04

Low

$1.01

Volume

65.9K

Market Cap

$26.52M

About ABVC BioPharma, Inc. Common Stock

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 19 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-1,689,937	$-0.06
FY 2025	$0	$-8,376,959	$-0.39
Q3 2025	$796.0K	$-1,287,523	$-0.05
Q1 2025	$0	$-944,190	$-0.06

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for ABVC yet. Check out our latest market news or earnings calendar.

Get ABVC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on ABVC BioPharma, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.